DE69526206D1 - Verwendung von interleukin-12 fuer die verhinderung von transplantat gegen empfaengerkrankheit - Google Patents

Verwendung von interleukin-12 fuer die verhinderung von transplantat gegen empfaengerkrankheit

Info

Publication number
DE69526206D1
DE69526206D1 DE69526206T DE69526206T DE69526206D1 DE 69526206 D1 DE69526206 D1 DE 69526206D1 DE 69526206 T DE69526206 T DE 69526206T DE 69526206 T DE69526206 T DE 69526206T DE 69526206 D1 DE69526206 D1 DE 69526206D1
Authority
DE
Germany
Prior art keywords
interleukin
disease
prevention
against receiver
transplant against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69526206T
Other languages
English (en)
Other versions
DE69526206T2 (de
Inventor
F Wolf
Megan Sykes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Genetics Institute LLC
Original Assignee
General Hospital Corp
Genetics Institute LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp, Genetics Institute LLC filed Critical General Hospital Corp
Application granted granted Critical
Publication of DE69526206D1 publication Critical patent/DE69526206D1/de
Publication of DE69526206T2 publication Critical patent/DE69526206T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5434—IL-12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/208—IL-12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
DE69526206T 1994-01-21 1995-01-20 Verwendung von interleukin-12 fuer die verhinderung von transplantat gegen empfaengerkrankheit Expired - Lifetime DE69526206T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/186,529 US5573764A (en) 1994-01-21 1994-01-21 Use of interleukin-12 to prevent graft versus host disease
PCT/US1995/000879 WO1995019786A1 (en) 1994-01-21 1995-01-20 Use of interleukin-12 to prevent graft versus host disease

Publications (2)

Publication Number Publication Date
DE69526206D1 true DE69526206D1 (de) 2002-05-08
DE69526206T2 DE69526206T2 (de) 2002-11-21

Family

ID=22685309

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69526206T Expired - Lifetime DE69526206T2 (de) 1994-01-21 1995-01-20 Verwendung von interleukin-12 fuer die verhinderung von transplantat gegen empfaengerkrankheit

Country Status (14)

Country Link
US (2) US5573764A (de)
EP (1) EP0739212B1 (de)
JP (1) JP3825043B2 (de)
AT (1) ATE215380T1 (de)
AU (1) AU698410B2 (de)
CA (1) CA2181568C (de)
DE (1) DE69526206T2 (de)
DK (1) DK0739212T3 (de)
ES (1) ES2179096T3 (de)
IL (1) IL112373A (de)
PT (1) PT739212E (de)
TW (1) TW349021B (de)
WO (1) WO1995019786A1 (de)
ZA (1) ZA95463B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5573764A (en) * 1994-01-21 1996-11-12 Genetics Institute, Inc. Use of interleukin-12 to prevent graft versus host disease
US5674483A (en) * 1995-01-31 1997-10-07 National Jewish Medical And Research Center Treatment for diseases involving inflammation
JP2000510813A (ja) * 1995-02-06 2000-08-22 ジェネテイックス・インスティテュート・インコーポレイテッド Ｉｌ−１２用処方
AU7482696A (en) * 1995-11-01 1997-05-22 Genetics Institute Inc. Methods for administration of il-12
WO1998017689A2 (en) * 1996-10-18 1998-04-30 Valentis Inc. Il-12 gene expression and delivery systems and uses
CA2268276A1 (en) * 1996-10-18 1998-04-30 Jeff Nordstrom Gene expression and delivery systems and uses
AU6150498A (en) * 1997-02-07 1998-08-26 Wistar Institute, The Methods and compositions for the inhibition of interleukin-12 production
WO1998051327A1 (fr) * 1997-05-16 1998-11-19 Toray Industries, Inc. Agent therapeutique, procede de traitement, agent prophylactique et procede prophylactique destines au traitement de maladies immunologiques chez les chiens et les chats
EP1516630A3 (de) * 1997-10-31 2006-05-03 Wyeth Verwendung von anti-il-12 Antikörpern bei Transplantationsabstossungen
US6080399A (en) * 1998-04-23 2000-06-27 Arch Development Corporation Vaccine adjuvants for immunotherapy of melanoma
US7115712B1 (en) * 1999-12-02 2006-10-03 Maxygen, Inc. Cytokine polypeptides
US7638496B2 (en) 2000-02-15 2009-12-29 Valeant Pharmaceuticals North America Nucleoside analogs with carboxamidine modified monocyclic base
US20040175827A1 (en) * 2001-07-02 2004-09-09 Fowler Daniel H. Methods of generating human cd4+ th2 cells and uses thereof
WO2003038062A2 (en) * 2001-10-31 2003-05-08 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Generation of use of tc1 and tc2 cells
US20040241153A1 (en) * 2001-08-31 2004-12-02 Fowler Daniel H. Methods of generating human cd4+ th1 cells
US7718196B2 (en) * 2001-07-02 2010-05-18 The United States Of America, As Represented By The Department Of Health And Human Services Rapamycin-resistant T cells and therapeutic uses thereof
DE10248141B4 (de) * 2002-10-11 2007-04-19 Universitätsklinikum Hamburg-Eppendorf Nukleinsäuren und deren Verwendung für die Gentherapie
US7939058B2 (en) 2003-07-03 2011-05-10 University Of Southern California Uses of IL-12 in hematopoiesis
JP2010539993A (ja) * 2007-10-08 2010-12-24 イントレキソン コーポレーション 遺伝子操作した樹状細胞および癌の治療のための使用
US20100272863A1 (en) * 2009-04-24 2010-10-28 Griebel Jonathan M Soft shaped tortillas
EP2571516B1 (de) 2010-05-18 2017-11-15 Neumedicines, Inc Formulierungen enthaltend il-12 zur erhöhung der hematopoese
WO2012174056A1 (en) 2011-06-13 2012-12-20 Neumedicines, Inc. Mitigation of cutaneous injury with il-12
WO2013016634A1 (en) 2011-07-27 2013-01-31 Neumedicines, Inc. Use of il-12 to generate endogenous erythropoietin
US11951157B2 (en) 2011-10-11 2024-04-09 Universitat Zurich Methods of treating malignant tumour with IL-12 and anti-PD-1 antibody
WO2013053775A1 (en) * 2011-10-11 2013-04-18 Universität Zürich Prorektorat Mnw Combination medicament comprising il-12 and an agent for blockade of t-cell inhibitory molecules for tumour therapy
US9636381B2 (en) 2012-01-18 2017-05-02 Neumedicines, Inc. Methods for radiation protection by administering IL-12
WO2013158959A1 (en) * 2012-04-19 2013-10-24 Tarix Pharmaceuticals Ltd. Compositions and methods for treatment of graft-versus-host disease
KR20230004646A (ko) * 2020-04-17 2023-01-06 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 조작된 il-12 및 il-23 폴리펩타이드 및 이의 용도
EP4228610A1 (de) * 2020-10-13 2023-08-23 Kriya Therapeutics, Inc. Virale vektorkonstrukte zur abgabe von cytokin-codierenden nukleinsäuren und verwendungen davon zur behandlung von krebs

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA931489B (en) * 1992-03-04 1993-10-28 Schering Corp Use of interleuken-10 to suppress graft-vs-host disease
DE4315127A1 (de) * 1993-05-07 1994-11-10 Behringwerke Ag Arzneimittel enthaltend die Untereinheit p40 von Interleukin-12
US5573764A (en) * 1994-01-21 1996-11-12 Genetics Institute, Inc. Use of interleukin-12 to prevent graft versus host disease

Also Published As

Publication number Publication date
IL112373A (en) 2006-08-01
JP3825043B2 (ja) 2006-09-20
CA2181568A1 (en) 1995-07-27
EP0739212A1 (de) 1996-10-30
AU698410B2 (en) 1998-10-29
EP0739212B1 (de) 2002-04-03
ZA95463B (en) 1995-09-27
WO1995019786A1 (en) 1995-07-27
DE69526206T2 (de) 2002-11-21
DK0739212T3 (da) 2002-06-03
CA2181568C (en) 2007-09-18
IL112373A0 (en) 1995-03-30
TW349021B (en) 1999-01-01
US5573764A (en) 1996-11-12
ATE215380T1 (de) 2002-04-15
AU1687595A (en) 1995-08-08
PT739212E (pt) 2002-08-30
ES2179096T3 (es) 2003-01-16
US5756085A (en) 1998-05-26
JPH09508371A (ja) 1997-08-26

Similar Documents

Publication Publication Date Title
DE69526206D1 (de) Verwendung von interleukin-12 fuer die verhinderung von transplantat gegen empfaengerkrankheit
PL323825A1 (en) Peptidyloheterocycli compounds useful in treating diorders associated with thrombosin
IL144294A0 (en) P53 inhibitors and therapeutic use of the same
FR2709246B1 (fr) Orthèse vertébrale implantée dynamique.
DK0706521T3 (da) Imider som TNF-alfa-inhibitorer
TR199701212T1 (xx) �drar� tutamama halinin tedavisi i�in alfa IL- agonistlerinin kullan�lmas�.
AU2713600A (en) Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia
DK0755249T3 (da) Anvendelse af Maillard-reaktionsinhibitor til behandling af amyloidose-baseret sygdom
ID27414A (id) Penghambat-penghambat non-peptidil dari pengikat sel tergantung vla-4 yang bermanfaat dalam pengobatan penyakit-penyakit inflamasi, autoimun dan pernafasan
DE69432125T2 (de) Geldprüfer
ZA931174B (en) Treatment of disease employing hyaluronic acid and nsaids.
UA66793C2 (uk) Лептин як стримувач швидкого збільшення пухлини клітини
NZ504419A (en) The use of carvedilol for treating amyloid diseases such as Alzheimer's
ZA975288B (en) The use of TCET in the prophylaxis and treatment of allergies.
WO1996002240A3 (en) Use of inhibitors of human s-cd23
DE59004277D1 (de) Copolymerisat sowie dessen Verwendung.
FR2713444B1 (fr) Composition liquide désinfectante et ses utilisations.
WO1996005845A3 (en) Treatment of disease and conditions associated with macrophage infiltration in particular stroke and myocardial infarction
EP0938898A3 (de) Behandlung von Pruritus
GB9916729D0 (en) Fuller for the treatment of leather,pelts and the like
ZA9711468B (en) New use of comt inhibitors
AP9701148A0 (en) Dimesylate salts of neuropeptide Y ligands.
TR200003084T2 (tr) Paroxetine askorbat
EP0745597A3 (de) Melatonergische Indanylpiperazine oder Homopiperazine
ZA977004B (en) Therapeutic product and its use

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: GENETICS INSTITUTE,LLC(N.D.GES.D.STAATES DELAWARE)

Owner name: THE GENERAL HOSPITAL CORP., BOSTON, MASS., US